Chinese DNA giant BGI establishes European headquarters and research centre in Denmark  

One of the world’s leading genome centres, Chinese BGI, has announced plans to establish European headquarters in Copenhagen. The venture is the largest ever Chinese biotech investment in Denmark and BGI expects a first year turnover of DKK 5 billion (USD 1 billion).
“Denmark has a solid base within scientific research and development. Copenhagen’s good reputation as a sound business city and the city’s great flight connections to all of the European capitals, meant that we chose Denmark as our European headquarters and research centre,” said Mason Mak, CEO of BGI’s European activities to Danish financial newspaper Børsen.
The announcement was made yesterday at the Denmark-China Economic & Trade Cooperation Forum, an event organised by Invest in Denmark, where a delegation of more than 100 Chinese business executives, alongside China’s Minister of Commerce, Mr. Chen Deming, and the Danish Minister of Foreign Affairs, Mrs. Lene Espersen, participated. The delegation was the largest Chinese business delegation ever to visit Denmark.
BGI plans to invest USD 10 million and hire between 20-50 employees the first year and hopes to add a further 50-100 employees on the staff list in following years.

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×